Press Releases

Press Releases

Gilead Sciences, Inc. announced today that its fourth quarter and full year 2015 financial results will be released on Tuesday, February 2, at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the fourth quarter and…

Press Releases

Array BioPharma Inc. will report financial results for the second quarter of fiscal 2016 and hold a conference call to discuss those results on Tuesday, February 2, 2016.  Ron Squarer, Chief Executive Officer, will lead the call. Date:     Tuesday, February 2, 2016 Time:     9:00 a.m. Eastern Time Toll-Free:     (844) 464-3927…

Press Releases

Cleveland.com, the influential online news website covering and serving Northeast Ohio, published an editorial earlier today urging speedy legal action on an election dispute over an Ohio drug pricing ballot measure seeking to qualify for the November 2016 presidential election ballot. The editorial, titled, “Courts must move speedily on Ohio…

Press Releases

Oxford Global Conferences are proud to present the final agenda for its Inaugural Genetics in Forensics Congress taking place on the 14th & 15th March in London, UK. Join us to idea-share with over 150 senior level attendees about the future of sequencing technologies in forensic science and discover the…

Press Releases

Oxford Global is delighted to share with you the final agenda for our highly anticipated 3rd Annual Peptides Congress, taking place on 18th & 19th April 2016 at the Novotel London West, in London, UK. Join 400 senior level biologics experts and hear world-class presentations and keynote addresses covering the…

Press Releases

Turing Pharmaceuticals AG today announced that Nancy Retzlaff, Chief Commercial Officer, will testify before a U.S. House Committee on Oversight and Government Reform hearing on drug pricing on Tuesday, January 26. Turing, a privately held biopharmaceutical company focused on commercializing and developing innovative treatments for rare and neglected diseases and…

Press Releases

Israeli biotechnology company Kadimastem announces it has received patent allowance from the United States Patent and Trademark Office, for its innovative technology in the field of diabetes treatment. The patent is for a method of producing insulin-secreting cells from stem cells, and it is likely to constitute the foundation for…

Press Releases

Mylan N.V. today announced that it will host a conference call and live webcast, including a slide presentation, on Wednesday, Feb. 10, 2016, at 4:30 p.m. ET, to review the company's financial results for the fourth quarter and year ended Dec. 31, 2015. The company also will provide its financial…

Press Releases

Oxeia Biopharmaceuticals, Inc., a biotechnology company, is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury. Oxeia's lead program, OXE-103, uniquely targets the metabolic injury and energy crisis underlying acute concussion pathology. OXE-103 restores mitochondrial homeostasis via a well-characterized mechanism of action and may…

Press Releases

Pall Corporation, a global leader in filtration, separation and purification, announced the signing of a supply agreement for KANEKAKanCapA,a leading Protein A (PrA) chromatography sorbent from KanekaCorporation, Japan for the primary capture of monoclonal antibodies from clarified cell culture. KANEKAKanCapA enables the high productivityaffinity capture of monoclonal antibodies and related…